查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595707

美容醫療的全球市場:產業分析·規模·佔有率·成長·趨勢·預測 (2024-2033年)

Cosmetic Procedures Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

主要的洞察

  • 美容醫學市場規模（2024 年）：1,439 億美元
  • 市場規模預測（2031 年）：3,356 億美元
  • 全球市場成長率（2024-2031 年）：複合年增長率 12.9%

推動市場成長的因素：

有幾個因素促進了美容醫學市場的擴張。一個關鍵的推動因素是，由於社群媒體和名人文化的影響，人們對增強年輕外觀和美學意識的渴望日益增長。此外，可支配收入水準的上升，尤其是在新興市場，使得美容醫學更容易被更廣泛的消費者所接受。技術進步，包括微創手術的開發，也正在推動市場向前發展。雷射換膚、身體輪廓和注射填充劑等非侵入性療程因其價格實惠且恢復時間快而越來越受歡迎。此外，人們對美容和美學意識的增強也鼓勵人們尋求專業美容療程以提高自尊和自信。

市場機會：

美容醫學市場擁有許多機會，特別是由於技術進步和對微創治療的需求不斷增加。個人化美容療程（例如客製化皮膚護理方案和客製化治療）的日益普及代表著巨大的成長機會。醫療旅遊業的成長，即消費者前往能夠以實惠價格獲得優質治療的國家，也代表了一個尚未開發的收入來源。男性整容手術的興起也開闢了新的細分市場，越來越多的男性尋求毛髮移植和非手術面部護理等整容手術。人工智慧驅動的診斷工具和增強的患者護理技術等策略創新也有望進一步改變該產業。

本報告提供全球美容醫療的市場調查，提供市場定義和概要，推動市場要素·阻礙因素，各種趨勢，市場機會，課題，市場規模的轉變·預測，各種區分·各地區/主要國家的詳細分析，競爭環境，主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場定義
  • 市場分類

第3章 美容醫療:市場機會分析

  • 宏觀經濟要素
  • 機會分析
  • 價格分析

第4章 北美的美容醫療市場分析·預測

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 趨勢
  • 市場規模·治療數量的轉變:各國
  • 市場規模·治療數量的預測:各國
    • 美國
    • 加拿大
  • 市場規模·治療數量的轉變:各治療類型
  • 市場規模·治療數量的預測:各治療類型
    • 外科的治療
    • 非外科的治療
  • 市場規模·治療數量的轉變:各終端用戶
  • 市場規模·治療數量的預測:各終端用戶
    • 醫院
    • 辦公室為基礎的設施
    • 門診病人手術中心
  • 市場魅力分析

第5章 南美的美容醫療市場分析·預測

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 趨勢
  • 市場規模·治療數量的轉變:各國
  • 市場規模·治療數量的預測:各國
    • 巴西
    • 墨西哥
    • 其他
  • 市場規模·治療數量的轉變:各治療類型
  • 市場規模·治療數量的預測:各治療類型
    • 外科的治療
    • 非外科的治療
  • 市場規模·治療數量的轉變:各終端用戶
  • 市場規模·治療數量的預測:各終端用戶
    • 醫院
    • 辦公室為基礎的設施
    • 門診病人手術中心
  • 市場魅力分析

第6章 歐洲的美容醫療市場分析·預測

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 趨勢
  • 市場規模·治療數量的轉變:各國
  • 市場規模·治療數量的預測:各國
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 市場規模·治療數量的轉變:各治療類型
  • 市場規模·治療數量的預測:各治療類型
    • 外科的治療
    • 非外科的治療
  • 市場規模·治療數量的轉變:各終端用戶
  • 市場規模·治療數量的預測:各終端用戶
    • 醫院
    • 辦公室為基礎的設施
    • 門診病人手術中心
  • 市場魅力分析

第7章 亞太地區的美容醫療市場分析·預測

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 趨勢
  • 市場規模·治療數量的轉變:各國
  • 市場規模·治療數量的預測:各國
    • 中國
    • 日本
    • 印度
    • 東南亞國協
    • 澳洲·紐西蘭
    • 其他
  • 市場規模·治療數量的轉變:各治療類型
  • 市場規模·治療數量的預測:各治療類型
    • 外科的治療
    • 非外科的治療
  • 市場規模·治療數量的轉變:各終端用戶
  • 市場規模·治療數量的預測:各終端用戶
    • 醫院
    • 辦公室為基礎的設施
    • 門診病人手術中心
  • 市場魅力分析

第8章 中東·非洲的美容醫療市場分析·預測

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 趨勢
  • 市場規模·治療數量的轉變:各國
  • 市場規模·治療數量的預測:各國
    • GCC各國
    • 南非
    • 北非
    • 其他
  • 市場規模·治療數量的轉變:各治療類型
  • 市場規模·治療數量的預測:各治療類型
    • 外科的治療
    • 非外科的治療
  • 市場規模·治療數量的轉變:各終端用戶
  • 市場規模·治療數量的預測:各終端用戶
    • 醫院
    • 辦公室為基礎的
    • 門診病人手術中心
  • 市場魅力分析

第9章 預測要素:重要性·影響

第10章 競爭情形

  • 競爭儀表板
  • 企業及服務供應商的簡介
    • Allergan, Plc
    • Mentor Worldwide LLC (Johnson & Johnson Services, Inc.)
    • GC Aesthetics
    • Sientra, Inc
    • Polytech Health & Aesthetics GmbH
    • HansBiomed Co., Ltd
    • Galderma S.A. (A Nestle Company
    • Alma Lasers Ltd. (Shanghai Fosun Pharmaceuticals Ltd.)
    • Merz Pharma GmbH & Co. KGaA
    • Cutera, Inc
    • Anika Therapeutics, Inc.)
    • Valeant Pharmaceuticals International, Inc.
    • Syneron Medical Ltd.
    • Cynosure Inc. (Hologic Inc.)
    • Suneva Medical, Inc.
    • Blue Plastic Surgery
    • Australia Cosmetic Clinics
    • Salmon Creek Plastic Surgery
    • The Plastic Surgery Clinic
    • Cosmetic Surgery (UK) Limited

第11章 全球美容醫療市場分析·預測:各地區

  • 市場規模·治療數量的轉變
  • 市場規模·治療數量的預測
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東·非洲
  • 市場魅力分析

第12章 全球美容醫療市場分析·預測:各治療類型

  • 市場規模·治療數量的轉變
  • 市場規模·治療數量的預測
    • 外科的治療
    • 非外科的治療
  • 市場魅力分析

第13章 全球美容醫療市場分析·預測:各終端用戶

  • 市場規模·治療數量的轉變
  • 市場規模·治療數量的預測
    • 醫院
    • 辦公室為基礎的
    • 門診病人手術中心
  • 市場魅力分析

第14章 全球美容醫療市場分析·預測

  • 市場規模·與前一年同期比較成長率
  • 商機
簡介目錄
Product Code: PMRREP18637

Persistence Market Research has recently unveiled a detailed report on the global Cosmetic Procedures Market, offering comprehensive analysis and insights on key market dynamics such as drivers, trends, opportunities, and challenges. This publication provides exclusive data and statistics, detailing the projected growth trajectory of the global cosmetic procedures market from 2024 to 2031.

Key Insights:

  • Cosmetic Procedures Market Size (2024E): USD 143.9 Billion
  • Projected Market Value (2031F): USD 335.6 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 12.9%

Cosmetic Procedures Market - Report Scope:

The cosmetic procedures market is witnessing rapid growth, driven by increasing consumer interest in aesthetic enhancements, technological advancements, and greater access to non-invasive treatments. The market includes both surgical and non-surgical procedures, with the latter being more popular due to their minimal recovery time and lower costs. Surgeons, dermatologists, and medical aesthetic clinics are the primary service providers, offering treatments such as botox injections, liposuction, rhinoplasty, and skin rejuvenation.

Market Growth Drivers:

Several factors are contributing to the expansion of the cosmetic procedures market. A significant driver is the growing desire for youthful appearance and aesthetic enhancements, fueled by social media influences and celebrity culture. Additionally, rising disposable income levels, particularly in emerging markets, have made cosmetic procedures more accessible to a broader consumer base. Technological advancements, including the development of less invasive procedures, are also pushing the market forward. Non-invasive treatments, such as laser skin resurfacing, body contouring, and injectable fillers, are gaining popularity due to their affordability and faster recovery times. Moreover, rising awareness regarding personal grooming and aesthetics is prompting individuals to seek professional cosmetic treatments for self-esteem and confidence enhancement.

Market Restraints:

Despite its growth, the cosmetic procedures market faces challenges that may hinder its expansion. One of the key restraints is the high cost of certain procedures, particularly surgical ones, which may limit access for a broader segment of the population. Additionally, complications and risks associated with some procedures, such as infections or dissatisfaction with results, could deter potential patients. The cosmetic surgery industry also faces regulatory challenges, with varying standards across regions, leading to concerns over safety and quality control. Lastly, societal pressures to maintain certain beauty standards and the increasing prevalence of "cosmetic surgery tourism" can create ethical and psychological challenges.

Market Opportunities:

The cosmetic procedures market is ripe with opportunities, particularly due to advancements in technology and the increasing demand for minimally invasive treatments. The growing popularity of personalized aesthetic treatments, such as customized skin care regimens and tailored procedures, offers significant opportunities for growth. Additionally, the expansion of medical tourism, where consumers travel to countries with affordable and high-quality procedures, presents an untapped revenue stream. The rise in male cosmetic procedures also opens new market segments, as men increasingly seek aesthetic treatments such as hair transplants and non-surgical facial treatments. Strategic innovations, including AI-powered diagnostic tools and enhanced patient care technologies, are expected to further transform the industry.

Key Questions Answered in the Report:

  • What are the major factors driving the growth of the global cosmetic procedures market?
  • What are the most popular cosmetic procedures by region, and how is demand shifting across them?
  • How are technological advancements, such as lasers and AI, reshaping the market for cosmetic procedures?
  • What are the emerging trends, including the rise of male cosmetic procedures and non-invasive treatments?
  • Who are the key players in the cosmetic procedures market, and how are they maintaining a competitive edge?

Competitive Intelligence and Business Strategy:

Leading players in the global cosmetic procedures market, including Allergan, Galderma, Johnson & Johnson, and Merz Pharmaceuticals, are focusing on strategic partnerships, acquisitions, and expanding their product offerings to remain competitive. Companies are investing heavily in R&D to develop new, innovative treatments, with a particular emphasis on minimally invasive and non-surgical options. Additionally, key players are focusing on expanding their market presence in emerging economies, where demand for cosmetic procedures is rapidly increasing. Data privacy, safety standards, and post-procedure care are also critical areas of focus, as companies work to build trust and ensure patient satisfaction across the globe.

Key Companies Profiled:

  • Allergan, Plc
  • Mentor Worldwide LLC (Johnson & Johnson Services, Inc.)
  • GC Aesthetics
  • Sientra, Inc
  • Polytech Health & Aesthetics GmbH
  • HansBiomed Co., Ltd
  • Galderma S.A. (A Nestle Company
  • Alma Lasers Ltd. (Shanghai Fosun Pharmaceuticals Ltd.)
  • Merz Pharma GmbH & Co. KGaA
  • Cutera, Inc
  • Anika Therapeutics, Inc.)
  • Valeant Pharmaceuticals International, Inc.
  • Syneron Medical Ltd.
  • Cynosure Inc. (Hologic Inc.)
  • Suneva Medical, Inc.
  • Blue Plastic Surgery
  • Australia Cosmetic Clinics
  • Salmon Creek Plastic Surgery
  • The Plastic Surgery Clinic
  • Cosmetic Surgery (UK) Limited

Market Nomenclature

By Procedure Type

  • Surgical Procedures
  • Non-Surgical Procedures

By End User

  • Hospitals
  • Office-based Facilities
  • Ambulatory Surgical Centers

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Cosmetic Procedures Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis
  • 3.3. Pricing Analysis

4. North America Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033

  • 4.1. Introduction
  • 4.2. Regional Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Trends
  • 4.3. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Country, 2019-2023
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Market Size (US$ Bn) and Procedure Volume Forecast By Country, 2024-2033
    • 4.4.1. U.S.
    • 4.4.2. Canada
  • 4.5. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Procedure Type, 2019-2023
    • 4.5.1. Surgical Procedure
      • 4.5.1.1. Breast Surgery
        • 4.5.1.1.1. Breast Augmentation
        • 4.5.1.1.2. Breast Lift
        • 4.5.1.1.3. Breast Reduction
      • 4.5.1.2. Body and Extremities
        • 4.5.1.2.1. Liposuction
        • 4.5.1.2.2. Abdominoplasty
      • 4.5.1.3. Face Surgery
        • 4.5.1.3.1. Rhinoplasty
        • 4.5.1.3.2. Blepharoplasty
        • 4.5.1.3.3. Facelift
    • 4.5.2. Non-Surgical Procedure
      • 4.5.2.1. Injectables
        • 4.5.2.1.1. Botulinum Toxin
        • 4.5.2.1.2. Hyaluronic Acid
      • 4.5.2.2. Facial Rejuvenation
        • 4.5.2.2.1. Photo Rejuvenation
        • 4.5.2.2.2. Chemical Peel
        • 4.5.2.2.3. Microdermabrasion
        • 4.5.2.2.4. Non-Surgical Skin Tightening
        • 4.5.2.2.5. Laser Skin Resurfacing
      • 4.5.2.3. Others
        • 4.5.2.3.1. Hair Removal
        • 4.5.2.3.2. Tattoo Removal
  • 4.6. Market Size (US$ Bn) and Procedure Volume Forecast By Procedure Type, 2024-2033
    • 4.6.1. Surgical Procedure
      • 4.6.1.1. Breast Surgery
        • 4.6.1.1.1. Breast Augmentation
        • 4.6.1.1.2. Breast Lift
        • 4.6.1.1.3. Breast Reduction
      • 4.6.1.2. Body and Extremities
        • 4.6.1.2.1. Liposuction
        • 4.6.1.2.2. Abdominoplasty
      • 4.6.1.3. Face Surgery
        • 4.6.1.3.1. Rhinoplasty
        • 4.6.1.3.2. Blepharoplasty
        • 4.6.1.3.3. Facelift
    • 4.6.2. Non-Surgical Procedure
      • 4.6.2.1. Injectables
        • 4.6.2.1.1. Botulinum Toxin
        • 4.6.2.1.2. Hyaluronic Acid
      • 4.6.2.2. Facial Rejuvenation
        • 4.6.2.2.1. Photo Rejuvenation
        • 4.6.2.2.2. Chemical Peel
        • 4.6.2.2.3. Microdermabrasion
        • 4.6.2.2.4. Non-Surgical Skin Tightening
        • 4.6.2.2.5. Laser Skin Resurfacing
      • 4.6.2.3. Others
        • 4.6.2.3.1. Hair Removal
        • 4.6.2.3.2. Tattoo Removal
  • 4.7. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By End User, 2019-2023
    • 4.7.1. Hospitals
    • 4.7.2. Office Based Facility
    • 4.7.3. Ambulatory Surgical Centers
  • 4.8. Market Size (US$ Bn) and Procedure Volume Forecast By End User, 2024-2033
    • 4.8.1. Hospitals
    • 4.8.2. Office Based Facility
    • 4.8.3. Ambulatory Surgical Centers
  • 4.9. Market Attractiveness Analysis
    • 4.9.1. By Country
    • 4.9.2. By Procedure Type
    • 4.9.3. By End User

5. Latin America Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033

  • 5.1. Introduction
  • 5.2. Regional Market Dynamics
    • 5.2.1. Drivers
    • 5.2.2. Restraints
    • 5.2.3. Trends
  • 5.3. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Country, 2019-2023
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Market Size (US$ Bn) and Procedure Volume Forecast By Country, 2024-2033
    • 5.4.1. Brazil
    • 5.4.2. Mexico
    • 5.4.3. Rest of Latin America
  • 5.5. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Procedure Type, 2019-2023
    • 5.5.1. Surgical Procedure
      • 5.5.1.1. Breast Surgery
        • 5.5.1.1.1. Breast Augmentation
        • 5.5.1.1.2. Breast Lift
        • 5.5.1.1.3. Breast Reduction
      • 5.5.1.2. Body and Extremities
        • 5.5.1.2.1. Liposuction
        • 5.5.1.2.2. Abdominoplasty
      • 5.5.1.3. Face Surgery
        • 5.5.1.3.1. Rhinoplasty
        • 5.5.1.3.2. Blepharoplasty
        • 5.5.1.3.3. Facelift
    • 5.5.2. Non-Surgical Procedure
      • 5.5.2.1. Injectables
        • 5.5.2.1.1. Botulinum Toxin
        • 5.5.2.1.2. Hyaluronic Acid
      • 5.5.2.2. Facial Rejuvenation
        • 5.5.2.2.1. Photo Rejuvenation
        • 5.5.2.2.2. Chemical Peel
        • 5.5.2.2.3. Microdermabrasion
        • 5.5.2.2.4. Non-Surgical Skin Tightening
        • 5.5.2.2.5. Laser Skin Resurfacing
      • 5.5.2.3. Others
        • 5.5.2.3.1. Hair Removal
        • 5.5.2.3.2. Tattoo Removal
  • 5.6. Market Size (US$ Bn) and Procedure Volume Forecast By Procedure Type, 2024-2033
    • 5.6.1. Surgical Procedure
      • 5.6.1.1. Breast Surgery
        • 5.6.1.1.1. Breast Augmentation
        • 5.6.1.1.2. Breast Lift
        • 5.6.1.1.3. Breast Reduction
      • 5.6.1.2. Body and Extremities
        • 5.6.1.2.1. Liposuction
        • 5.6.1.2.2. Abdominoplasty
      • 5.6.1.3. Face Surgery
        • 5.6.1.3.1. Rhinoplasty
        • 5.6.1.3.2. Blepharoplasty
        • 5.6.1.3.3. Facelift
    • 5.6.2. Non-Surgical Procedure
      • 5.6.2.1. Injectables
        • 5.6.2.1.1. Botulinum Toxin
        • 5.6.2.1.2. Hyaluronic Acid
      • 5.6.2.2. Facial Rejuvenation
        • 5.6.2.2.1. Photo Rejuvenation
        • 5.6.2.2.2. Chemical Peel
        • 5.6.2.2.3. Microdermabrasion
        • 5.6.2.2.4. Non-Surgical Skin Tightening
        • 5.6.2.2.5. Laser Skin Resurfacing
      • 5.6.2.3. Others
        • 5.6.2.3.1. Hair Removal
        • 5.6.2.3.2. Tattoo Removal
  • 5.7. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By End User, 2019-2023
    • 5.7.1. Hospitals
    • 5.7.2. Office Based Facility
    • 5.7.3. Ambulatory Surgical Centers
  • 5.8. Market Size (US$ Bn) and Procedure Volume Forecast By End User, 2024-2033
    • 5.8.1. Hospitals
    • 5.8.2. Office Based Facility
    • 5.8.3. Ambulatory Surgical Centers
  • 5.9. Market Attractiveness Analysis
    • 5.9.1. By Country
    • 5.9.2. By Procedure Type
    • 5.9.3. By End User

6. Europe Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033

  • 6.1. Introduction
  • 6.2. Regional Market Dynamics
    • 6.2.1. Drivers
    • 6.2.2. Restraints
    • 6.2.3. Trends
  • 6.3. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Country, 2019-2023
    • 6.3.1. Germany
    • 6.3.2. U.K.
    • 6.3.3. France
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Russia
    • 6.3.7. Rest of Europe
  • 6.4. Market Size (US$ Bn) and Procedure Volume Forecast By Country, 2024-2033
    • 6.4.1. Germany
    • 6.4.2. U.K.
    • 6.4.3. France
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Rest of Europe
  • 6.5. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Procedure Type, 2019-2023
    • 6.5.1. Surgical Procedure
      • 6.5.1.1. Breast Surgery
        • 6.5.1.1.1. Breast Augmentation
        • 6.5.1.1.2. Breast Lift
        • 6.5.1.1.3. Breast Reduction
      • 6.5.1.2. Body and Extremities
        • 6.5.1.2.1. Liposuction
        • 6.5.1.2.2. Abdominoplasty
      • 6.5.1.3. Face Surgery
        • 6.5.1.3.1. Rhinoplasty
        • 6.5.1.3.2. Blepharoplasty
        • 6.5.1.3.3. Facelift
    • 6.5.2. Non-Surgical Procedure
      • 6.5.2.1. Injectables
        • 6.5.2.1.1. Botulinum Toxin
        • 6.5.2.1.2. Hyaluronic Acid
      • 6.5.2.2. Facial Rejuvenation
        • 6.5.2.2.1. Photo Rejuvenation
        • 6.5.2.2.2. Chemical Peel
        • 6.5.2.2.3. Microdermabrasion
        • 6.5.2.2.4. Non-Surgical Skin Tightening
        • 6.5.2.2.5. Laser Skin Resurfacing
      • 6.5.2.3. Others
        • 6.5.2.3.1. Hair Removal
        • 6.5.2.3.2. Tattoo Removal
  • 6.6. Market Size (US$ Bn) and Procedure Volume Forecast By Procedure Type, 2024-2033
    • 6.6.1. Surgical Procedure
      • 6.6.1.1. Breast Surgery
        • 6.6.1.1.1. Breast Augmentation
        • 6.6.1.1.2. Breast Lift
        • 6.6.1.1.3. Breast Reduction
      • 6.6.1.2. Body and Extremities
        • 6.6.1.2.1. Liposuction
        • 6.6.1.2.2. Abdominoplasty
      • 6.6.1.3. Face Surgery
        • 6.6.1.3.1. Rhinoplasty
        • 6.6.1.3.2. Blepharoplasty
        • 6.6.1.3.3. Facelift
    • 6.6.2. Non-Surgical Procedure
      • 6.6.2.1. Injectables
        • 6.6.2.1.1. Botulinum Toxin
        • 6.6.2.1.2. Hyaluronic Acid
      • 6.6.2.2. Facial Rejuvenation
        • 6.6.2.2.1. Photo Rejuvenation
        • 6.6.2.2.2. Chemical Peel
        • 6.6.2.2.3. Microdermabrasion
        • 6.6.2.2.4. Non-Surgical Skin Tightening
        • 6.6.2.2.5. Laser Skin Resurfacing
      • 6.6.2.3. Others
        • 6.6.2.3.1. Hair Removal
        • 6.6.2.3.2. Tattoo Removal
  • 6.7. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By End User, 2019-2023
    • 6.7.1. Hospitals
    • 6.7.2. Office Based Facility
    • 6.7.3. Ambulatory Surgical Centers
  • 6.8. Market Size (US$ Bn) and Procedure Volume Forecast By End User, 2024-2033
    • 6.8.1. Hospitals
    • 6.8.2. Office Based Facility
    • 6.8.3. Ambulatory Surgical Centers
  • 6.9. Market Attractiveness Analysis
    • 6.9.1. By Country
    • 6.9.2. By Procedure Type
    • 6.9.3. By End User

7. Asia Pacific Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033

  • 7.1. Introduction
  • 7.2. Regional Market Dynamics
    • 7.2.1. Drivers
    • 7.2.2. Restraints
    • 7.2.3. Trends
  • 7.3. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Country, 2019-2023
    • 7.3.1. China
    • 7.3.2. Japan
    • 7.3.3. India
    • 7.3.4. ASEAN
    • 7.3.5. Australia and New Zealand
    • 7.3.6. Rest of Asia Pacific
  • 7.4. Market Size (US$ Bn) and Procedure Volume Forecast By Country, 2024-2033
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. India
    • 7.4.4. ASEAN
    • 7.4.5. Australia and New Zealand
    • 7.4.6. Rest of Asia Pacific
  • 7.5. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Procedure Type, 2019-2023
    • 7.5.1. Surgical Procedure
      • 7.5.1.1. Breast Surgery
        • 7.5.1.1.1. Breast Augmentation
        • 7.5.1.1.2. Breast Lift
        • 7.5.1.1.3. Breast Reduction
      • 7.5.1.2. Body and Extremities
        • 7.5.1.2.1. Liposuction
        • 7.5.1.2.2. Abdominoplasty
      • 7.5.1.3. Face Surgery
        • 7.5.1.3.1. Rhinoplasty
        • 7.5.1.3.2. Blepharoplasty
        • 7.5.1.3.3. Facelift
    • 7.5.2. Non-Surgical Procedure
      • 7.5.2.1. Injectables
        • 7.5.2.1.1. Botulinum Toxin
        • 7.5.2.1.2. Hyaluronic Acid
      • 7.5.2.2. Facial Rejuvenation
        • 7.5.2.2.1. Photo Rejuvenation
        • 7.5.2.2.2. Chemical Peel
        • 7.5.2.2.3. Microdermabrasion
        • 7.5.2.2.4. Non-Surgical Skin Tightening
        • 7.5.2.2.5. Laser Skin Resurfacing
      • 7.5.2.3. Others
        • 7.5.2.3.1. Hair Removal
        • 7.5.2.3.2. Tattoo Removal
  • 7.6. Market Size (US$ Bn) and Procedure Volume Forecast By Procedure Type, 2024-2033
    • 7.6.1. Surgical Procedure
      • 7.6.1.1. Breast Surgery
        • 7.6.1.1.1. Breast Augmentation
        • 7.6.1.1.2. Breast Lift
        • 7.6.1.1.3. Breast Reduction
      • 7.6.1.2. Body and Extremities
        • 7.6.1.2.1. Liposuction
        • 7.6.1.2.2. Abdominoplasty
      • 7.6.1.3. Face Surgery
        • 7.6.1.3.1. Rhinoplasty
        • 7.6.1.3.2. Blepharoplasty
        • 7.6.1.3.3. Facelift
    • 7.6.2. Non-Surgical Procedure
      • 7.6.2.1. Injectables
        • 7.6.2.1.1. Botulinum Toxin
        • 7.6.2.1.2. Hyaluronic Acid
      • 7.6.2.2. Facial Rejuvenation
        • 7.6.2.2.1. Photo Rejuvenation
        • 7.6.2.2.2. Chemical Peel
        • 7.6.2.2.3. Microdermabrasion
        • 7.6.2.2.4. Non-Surgical Skin Tightening
        • 7.6.2.2.5. Laser Skin Resurfacing
      • 7.6.2.3. Others
        • 7.6.2.3.1. Hair Removal
        • 7.6.2.3.2. Tattoo Removal
  • 7.7. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By End User, 2019-2023
    • 7.7.1. Hospitals
    • 7.7.2. Office Based Facility
    • 7.7.3. Ambulatory Surgical Centers
  • 7.8. Market Size (US$ Bn) and Procedure Volume Forecast By End User, 2024-2033
    • 7.8.1. Hospitals
    • 7.8.2. Office Based Facility
    • 7.8.3. Ambulatory Surgical Centers
  • 7.9. Market Attractiveness Analysis
    • 7.9.1. By Country
    • 7.9.2. By Procedure Type
    • 7.9.3. By End User

8. Middle East & Africa Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033

  • 8.1. Introduction
  • 8.2. Regional Market Dynamics
    • 8.2.1. Drivers
    • 8.2.2. Restraints
    • 8.2.3. Trends
  • 8.3. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Country, 2019-2023
    • 8.3.1. GCC Countries
    • 8.3.2. South Africa
    • 8.3.3. North Africa
    • 8.3.4. Rest of MEA
  • 8.4. Market Size (US$ Bn) and Procedure Volume Forecast By Country, 2024-2033
    • 8.4.1. GCC Countries
    • 8.4.2. South Africa
    • 8.4.3. North Africa
    • 8.4.4. Rest of MEA
  • 8.5. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Procedure Type, 2019-2023
    • 8.5.1. Surgical Procedure
      • 8.5.1.1. Breast Surgery
        • 8.5.1.1.1. Breast Augmentation
        • 8.5.1.1.2. Breast Lift
        • 8.5.1.1.3. Breast Reduction
      • 8.5.1.2. Body and Extremities
        • 8.5.1.2.1. Liposuction
        • 8.5.1.2.2. Abdominoplasty
      • 8.5.1.3. Face Surgery
        • 8.5.1.3.1. Rhinoplasty
        • 8.5.1.3.2. Blepharoplasty
        • 8.5.1.3.3. Facelift
    • 8.5.2. Non-Surgical Procedure
      • 8.5.2.1. Injectables
        • 8.5.2.1.1. Botulinum Toxin
        • 8.5.2.1.2. Hyaluronic Acid
      • 8.5.2.2. Facial Rejuvenation
        • 8.5.2.2.1. Photo Rejuvenation
        • 8.5.2.2.2. Chemical Peel
        • 8.5.2.2.3. Microdermabrasion
        • 8.5.2.2.4. Non-Surgical Skin Tightening
        • 8.5.2.2.5. Laser Skin Resurfacing
      • 8.5.2.3. Others
        • 8.5.2.3.1. Hair Removal
        • 8.5.2.3.2. Tattoo Removal
  • 8.6. Market Size (US$ Bn) and Procedure Volume Forecast By Procedure Type, 2024-2033
    • 8.6.1. Surgical Procedure
      • 8.6.1.1. Breast Surgery
        • 8.6.1.1.1. Breast Augmentation
        • 8.6.1.1.2. Breast Lift
        • 8.6.1.1.3. Breast Reduction
      • 8.6.1.2. Body and Extremities
        • 8.6.1.2.1. Liposuction
        • 8.6.1.2.2. Abdominoplasty
      • 8.6.1.3. Face Surgery
        • 8.6.1.3.1. Rhinoplasty
        • 8.6.1.3.2. Blepharoplasty
        • 8.6.1.3.3. Facelift
    • 8.6.2. Non-Surgical Procedure
      • 8.6.2.1. Injectables
        • 8.6.2.1.1. Botulinum Toxin
        • 8.6.2.1.2. Hyaluronic Acid
      • 8.6.2.2. Facial Rejuvenation
        • 8.6.2.2.1. Photo Rejuvenation
        • 8.6.2.2.2. Chemical Peel
        • 8.6.2.2.3. Microdermabrasion
        • 8.6.2.2.4. Non-Surgical Skin Tightening
        • 8.6.2.2.5. Laser Skin Resurfacing
      • 8.6.2.3. Others
        • 8.6.2.3.1. Hair Removal
        • 8.6.2.3.2. Tattoo Removal
  • 8.7. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By End User, 2019-2023
    • 8.7.1. Hospitals
    • 8.7.2. Office Based Facility
    • 8.7.3. Ambulatory Surgical Centers
  • 8.8. Market Size (US$ Bn) and Procedure Volume Forecast By End User, 2024-2033
    • 8.8.1. Hospitals
    • 8.8.2. Office Based Facility
    • 8.8.3. Ambulatory Surgical Centers
  • 8.9. Market Attractiveness Analysis
    • 8.9.1. By Country
    • 8.9.2. By Procedure Type
    • 8.9.3. By End User

9. Forecast Factors: Relevance and Impact

10. Competition Landscape

  • 10.1. Competition Dashboard
  • 10.2. Company and Service Provider Profiles (Details - Overview, Financials, Strategy, SWOT, Recent Developments)
    • 10.2.1. Allergan, Plc
    • 10.2.2. Mentor Worldwide LLC (Johnson & Johnson Services, Inc.)
    • 10.2.3. GC Aesthetics
    • 10.2.4. Sientra, Inc
    • 10.2.5. Polytech Health & Aesthetics GmbH
    • 10.2.6. HansBiomed Co., Ltd
    • 10.2.7. Galderma S.A. (A Nestle Company
    • 10.2.8. Alma Lasers Ltd. (Shanghai Fosun Pharmaceuticals Ltd.)
    • 10.2.9. Merz Pharma GmbH & Co. KGaA
    • 10.2.10. Cutera, Inc
    • 10.2.11. Anika Therapeutics, Inc.)
    • 10.2.12. Valeant Pharmaceuticals International, Inc.
    • 10.2.13. Syneron Medical Ltd.
    • 10.2.14. Cynosure Inc. (Hologic Inc.)
    • 10.2.15. Suneva Medical, Inc.
    • 10.2.16. Blue Plastic Surgery
    • 10.2.17. Australia Cosmetic Clinics
    • 10.2.18. Salmon Creek Plastic Surgery
    • 10.2.19. The Plastic Surgery Clinic
    • 10.2.20. Cosmetic Surgery (UK) Limited

11. Global Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction/Key Findings
  • 11.2. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Region, 2019-2023
    • 11.2.1. North America
    • 11.2.2. Latin America
    • 11.2.3. Europe
    • 11.2.4. Asia Pacific
    • 11.2.5. Middle East & Africa
  • 11.3. Market Size (US$ Bn) and Procedure Volume Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. Asia Pacific
    • 11.3.5. Middle East & Africa
  • 11.4. Market Attractiveness Analysis By Region

12. Global Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033, By Procedure Type

  • 12.1. Introduction/Key Findings
  • 12.2. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By Procedure Type, 2019-2023
    • 12.2.1. Surgical Procedure
      • 12.2.1.1. Breast Surgery
        • 12.2.1.1.1. Breast Augmentation
        • 12.2.1.1.2. Breast Lift
        • 12.2.1.1.3. Breast Reduction
      • 12.2.1.2. Body and Extremities
        • 12.2.1.2.1. Liposuction
        • 12.2.1.2.2. Abdominoplasty
      • 12.2.1.3. Face Surgery
        • 12.2.1.3.1. Rhinoplasty
        • 12.2.1.3.2. Blepharoplasty
        • 12.2.1.3.3. Facelift
    • 12.2.2. Non-Surgical Procedure
      • 12.2.2.1. Injectables
        • 12.2.2.1.1. Botulinum Toxin
        • 12.2.2.1.2. Hyaluronic Acid
      • 12.2.2.2. Facial Rejuvenation
        • 12.2.2.2.1. Photo Rejuvenation
        • 12.2.2.2.2. Chemical Peel
        • 12.2.2.2.3. Microdermabrasion
        • 12.2.2.2.4. Non-Surgical Skin Tightening
        • 12.2.2.2.5. Laser Skin Resurfacing
      • 12.2.2.3. Others
        • 12.2.2.3.1. Hair Removal
        • 12.2.2.3.2. Tattoo Removal
  • 12.3. Market Size (US$ Bn) and Procedure Volume Forecast By Procedure Type, 2024-2033
    • 12.3.1. Surgical Procedure
      • 12.3.1.1. Breast Surgery
        • 12.3.1.1.1. Breast Augmentation
        • 12.3.1.1.2. Breast Lift
        • 12.3.1.1.3. Breast Reduction
      • 12.3.1.2. Body and Extremities
        • 12.3.1.2.1. Liposuction
        • 12.3.1.2.2. Abdominoplasty
      • 12.3.1.3. Face Surgery
        • 12.3.1.3.1. Rhinoplasty
        • 12.3.1.3.2. Blepharoplasty
        • 12.3.1.3.3. Facelift
    • 12.3.2. Non-Surgical Procedure
      • 12.3.2.1. Injectables
        • 12.3.2.1.1. Botulinum Toxin
        • 12.3.2.1.2. Hyaluronic Acid
      • 12.3.2.2. Facial Rejuvenation
        • 12.3.2.2.1. Photo Rejuvenation
        • 12.3.2.2.2. Chemical Peel
        • 12.3.2.2.3. Microdermabrasion
        • 12.3.2.2.4. Non-Surgical Skin Tightening
        • 12.3.2.2.5. Laser Skin Resurfacing
      • 12.3.2.3. Others
        • 12.3.2.3.1. Hair Removal
        • 12.3.2.3.2. Tattoo Removal
  • 12.4. Market Attractiveness Analysis By Procedure Type

13. Global Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 13.1. Introduction/Key Findings
  • 13.2. Historical Market Size (US$ Bn) and Procedure Volume Trend Analysis By End User, 2019-2023
    • 13.2.1. Hospitals
    • 13.2.2. Office Based Facility
    • 13.2.3. Ambulatory Surgical Centers
  • 13.3. Market Size (US$ Bn) and Procedure Volume Forecast By End User, 2024-2033
    • 13.3.1. Hospitals
    • 13.3.2. Office Based Facility
    • 13.3.3. Ambulatory Surgical Centers
  • 13.4. Market Attractiveness Analysis By End User

14. Global Cosmetic Procedures Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Market Size and Y-o-Y Growth
  • 14.2. Absolute $ Opportunity